Mirafit fbcx reduces human body absorption of consumed fat

September 27, 2017

Data showed that significantly more weight was lost during the active phase as compared to the placebo phase of the study. Blood cholesterol, LDL (bad) cholesterol, and the atherogenic Apolipoprotein B levels were significantly reduced in the active phase while HDL (good) cholesterol levels remained unchanged. Participants with high triglyceride levels reduced their blood cholesterol levels more than twice as much relative to participants with normal triglyceride levels. In addition, the higher the cholesterol levels, the greater the cholesterol reduction in the active phase. Blood insulin levels were significantly reduced in the active phase as compared to those in the placebo phase, which suggests a reduced risk of developing type 2 diabetes. Unlike any other studied weight loss product, the participants were not put on a low fat or low calorie diet.

"These results indicate that mirafit fbcx not only exerts its beneficial health effects in obese individuals with type 2 diabetes, but also is effective in improving the blood lipid profile of apparently healthy non-obese individuals," said Dr. Artiss. "These findings build on previous animal and clinical studies."

Scientists have published substantial data from previous double-blind clinical trials with obese diabetic volunteers as well as numerous animal studies. The most recent research and prior, published scientific data suggest that:

-- mirafit fbcx is effective at reducing and/or maintaining body weight. -- mirafit fbcx lowers both triglyceride and LDL (bad) cholesterol levels in those patients with elevated triglyceride levels. -- mirafit fbcx, by increasing adiponectin levels in the blood, may delay the need for insulin in type 2 diabetics. -- mirafit fbcx has been shown to bind and remove nine times its own weight in dietary fat. -- mirafit fbcx appears to preferentially bind unhealthy saturated and trans fats over unsaturated dietary fats.

The active ingredient in mirafit fbcx, alpha-cyclodextrin, has been designated by the FDA as Generally Recognized As Safe (GRAS). The World Health Organization has given it an allowable daily intake of "not specified," suggesting that there is no unsafe level.

SOURCE: ArtJen Complexus USA, LLC